University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Azithromycin tablets

RICaD

Status: Amber Balsalazide

Consultant initiation - only when other agents have been ineffective

Status: Amber Bambuterol tablets

Specialist initiation for severe brittle asthma / CF 

Status: Amber Betamethasone 0.1% eye drops
Status: Amber Betamethasone 0.1%, neomycin 0.5% eye drops

Short term use only

Status: Amber Betaxolol eye drops

Specialist ophthalmologist recommendation
0.25% ophthalmic suspension
0.5% eye drops
0.5% unit dose eye drops

Status: Amber Bicalutamide tablets
Status: Amber Bimatoprost eye drops
Status: Amber Brinzolamide 1% and Brimonidine 0.2% eye drops (Simbrinza)

Specialist ophthalmologist recommendation

Status: Amber Brinzolamide eye drops

Specialist ophthalmologist recommendation

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top